Fungal Colonization in the Neonatal Intensive Care Unit: Risk Factors, Drug Susceptibility, and Association with Invasive Fungal Infections

Evangelia Farmaki; Joanna Evdoridou; Theodora Pouliou; Evangelia Bibashi; Paraskevi Panagopoulou; Joanna Filioti; Alexis Benos; Danai Sofianou; George Kremenopoulos; Emmanuel Roilides

doi:10.1055/s-2007-970078

American Journal of Perinatology, Table of Contents

Am J Perinatol 2007; 24(2): 127-135
DOI: 10.1055/s-2007-970078

Fungal Colonization in the Neonatal Intensive Care Unit: Risk Factors, Drug Susceptibility, and Association with Invasive Fungal Infections

Evangelia Farmaki¹ , Joanna Evdoridou² , Theodora Pouliou² , Evangelia Bibashi³ , Paraskevi Panagopoulou¹ , Joanna Filioti¹ , Alexis Benos⁴ , Danai Sofianou³ , George Kremenopoulos² , Emmanuel Roilides¹

¹3rd Department of Pediatrics, Aristotle University, Thessaloniki, Greece
²1st Department of Neonatology, Aristotle University, Thessaloniki, Greece
³Microbiology Department, Hippokration Hospital, Thessaloniki, Greece
⁴Laboratory of Hygiene, Medical School, Aristotle University, University Campus, Thessaloniki, Greece

Abstract

ABSTRACT

A prospective study was conducted to determine risk factors for fungal colonization, drug susceptibility, and association with invasive fungal infections (IFIs) in a neonatal unit. On admission and weekly thereafter, surveillance fungal cultures were taken from mouth, rectum, and trachea of neonates with expected stays of > 1 week. Fungal colonization was detected in 72 (12.1%) of 593 neonates during 12 months. Candida albicans was isolated from 42% of colonized neonates. Although early colonization (age 1.3 ± 0.2 days) was found in 2.5% of the neonates, late colonization (age 17.6 ± 1.4 days) was noted in 14.2% of neonates hospitalized for > 5 days. Neonates born vaginally were at higher risk for early colonization than those delivered after cesarean section (p = 0.01). By multivariate logistic regression, very low birthweight was the only independent risk factor for late colonization. Ten IFIs (nine candidemias) were diagnosed, yielding a rate of 1.1%. These episodes occurred in 6.9% of colonized neonates, compared with 0.76% of noncolonized neonates (p = 0.002). C. albicans was susceptible to azoles, but some non-albicans Candida spp. exhibited decreased susceptibility to these drugs.

KEYWORDS

Colonization - Candida spp. - neonate - drug susceptibility

Full Text

References

REFERENCES

1 Kossoff E H, Buescher E S, Karlowicz M G. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J. 1998; 17 504-508
2 Roilides E, Farmaki E, Evdoridou J et al.. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis. 2004; 23 745-750
3 Lopez Sastre J B, Coto Collado G D, Colomer B F et al.. Neonatal invasive candidiasis: A prospective multicenter study of 118 cases. Am J Perinatol. 2003; 20 153-163
4 Kaufman D. Fungal infection in the very low birthweight infant. Curr Opin Infect Dis. 2004; 17 253-259
5 El-Masry F A, Neal T J, Subhedar N V. Risk factors for invasive fungal infection in neonates. Acta Paediatr. 2002; 91 198-202
6 Roilides E, Kadiltsoglou I, Zahides D et al.. Invasive candidosis in pediatric patients. Clin Microbiol Infect. 1997; 3 192-197
7 Rangel-Frausto M S, Wiblin T, Blumberg H M et al.. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis. 1999; 29 253-258
8 Kaufman D, Boyle R, Hazen K C et al.. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med. 2001; 345 1660-1666
9 Kicklighter S D, Springer S C, Cox T et al.. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics. 2001; 107 293-298
10 Saiman L, Ludington E, Dawson J D et al.. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J. 2001; 20 1119-1124
11 Huang Y C, Li C C, Lin T Y et al.. Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect Dis J. 1998; 17 819-822
12 Waggoner-Fountain L A, Whit Walker M, Hollis R J et al.. Vertical and horizontal transmission of unique Candida species to premature newborns. Clin Infect Dis. 1996; 22 803-808
13 Reef S E, Lasker B A, Butcher D S et al.. Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: prospective study. J Clin Microbiol. 1998; 36 1255-1259
14 Lupetti A, Tavanti A, Davini P et al.. Horizontal transmission of Candida parapsilosis candidemia in a Neonatal Intensive Care Unit. J Clin Microbiol. 2002; 40 2363-2369
15 Saiman L, Ludington E, Pfaller M et al.. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J. 2000; 19 319-324
16 National Committee for Clinical Laboratory Standards .Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. Wayne, PA; National Committee for Clinical Laboratory Standards 2002
17 Rex J H, Pfaller M A, Galgiani J N et al.. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin Infect Dis. 1997; 24 235-247
18 Roilides E, Farmaki E, Evdoridou J et al.. Candida tropicalis in a neonatal intensive care unit: epidemiologic and molecular analysis of an outbreak of infection with an uncommon neonatal pathogen. J Clin Microbiol. 2003; 41 735-741
19 Huang Y, Lin T, Peng H et al.. Outbreak of Candida albicans fungaemia in a neonatal intensive care unit. Scand J Infect Dis. 1998; 30 137-142
20 Baley J E, Kliegman R M, Boxerbaum B et al.. Fungal colonization in the very low birth weight infant. Pediatrics. 1986; 78 225-232
21 Levy I, Rubin L G, Vasistha S et al.. Emergence of Candida parapsilosis as the predominant species causing candidaemia in children. Clin Infect Dis. 1998; 26 1086-1088
22 Sarvikivi E, Lyytikainen O, Soll D R et al.. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a Neonatal Intensive Care Unit. J Clin Microbiol. 2005; 43 2729-2735
23 Huang Y C, Lin R I, Chou Y H et al.. Candidaemia in special care nurseries: Comparison of albicans and parapsilosis infection. J Infect. 2000; 40 171-175
24 Faix R G, Finkel D J, Andersen R D et al.. Genotypic analysis of a cluster of systemic Candida albicans infections in a neonatal intensive care unit. Pediatr Infect Dis J. 1995; 14 1063-1068
25 Reagan D R, Pfaller M A, Hollis R J et al.. Evidence of nosocomial spread of Candida albicans causing bloodstream infection in a neonatal intensive care unit. Diagn Microbiol Infect Dis. 1995; 21 191-194
26 Welbel S F, McNeil M M, Kuykendall R J et al.. Candida parapsilosis bloodstream infections in neonatal intensive care unit patients: epidemiologic and laboratory confirmation of a common source outbreak. Pediatr Infect Dis J. 1996; 15 998-1002
27 Huang Y C, Lin T Y, Leu H S et al.. Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis. Infection. 1999; 27 97-102
28 da Silva C L, dos Santos R M, Colombo A L. Cluster of Candida parapsilosis primary bloodstream infection in a neonatal intensive care unit. Braz J Infect Dis. 2001; 5 32-36
29 Walsh T J, Merz W G. Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. . Am J Clin Pathol. 1986; 85 498-502
30 Leung A Y, Chim C S, Ho P L et al.. Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factors. J Hosp Infect. 2002; 50 316-319
31 Flynn P M, Marina N M, Rivera G K et al.. Candida tropicalis infections in children with leukemia. Leuk Lymphoma. 1993; 10 369-376
32 Sobel J D, Wiesenfeld H C, Martens M et al.. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004; 351 876-883
33 Girmenia C, Martino P, De Bernardis F et al.. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: Clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis. 1996; 23 506-514
34 el-Mohandes A E, Johnson-Robbins L, Keiser J F et al.. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease. Pediatr Infect Dis J. 1994; 13 520-524
35 Verma A, Wade J J, Cheeseman P et al.. Risk factors for fungal infection in paediatric liver transplant recipients. Pediatr Transplant. 2005; 9 220-225
36 Rowen J L, Tate J M, Nordoff N et al.. Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. J Clin Microbiol. 1999; 37 3735-3737

Emmanuel RoilidesM.D.

3rd Department of Pediatrics, Hippokration Hospital

Konstantinoupoleos 49, GR-546 42 Thessaloniki, Greece